Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
Journal of Cutaneous Pathology|April 20, 2018
Metastatic melanoma with balloon/histiocytoid cytomorphology after treatment with immunotherapy: A histologic mimic and diagnostic pitfallMaya Farah, Priyadharsini Nagarajan, Carlos A Torres-Cabala, et al.Cancer Medicine|March 9, 2021
The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanomaDai Ogata, Lauren E Haydu, Isabella C Glitza, et al.Melanoma Research|August 20, 2016
A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanomaJennifer L McQuade, Liberty P Posada, Srisuda Lecagoonporn, et al.Gynecologic Oncology|October 13, 2022
Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progressionDevarati Mitra, Morgan Farr, Priyadharsini Nagarajan, et al.Journal of Cutaneous Pathology|April 18, 2018
Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic featuresTsetan Dolkar, Celestine M Trinidad, Kelly C Nelson, et al.Journal for Immunotherapy of Cancer|February 14, 2018
Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patientsMichael T Tetzlaff, Kelly C Nelson, Adi Diab, et al.Head & Neck|February 5, 2025
Resectable Sinonasal Mucosal Melanoma in the Immunotherapy Era: Upfront Surgery vs. Neoadjuvant TherapyAya F Salem, Melissa M Chen, Michelle D Williams, et al.Practical Radiation Oncology|March 12, 2022
Outcomes After Sphincter-Sparing Local Therapy for Anorectal Melanoma: 1989 to 2020Devarati Mitra, Pallavi Krishna Rao, Priyadharsini Nagarajan, et al.Neuro-Oncology Practice|July 15, 2024
Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanomaChantal Saberian, Denái R Milton, Julie Simon, et al.Annals of Surgical Oncology|April 15, 2021
Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic EraDevarati Mitra, Gabriel Ologun, Emily Z Keung, et al.Pageof 9